cd /news/artificial-intelligence/reversing-ai-drug-discovery-belgian-… · home › topics › artificial-intelligence › article
[ARTICLE · art-63107] src=techfundingnews.com ↗ pub= topic=artificial-intelligence verified=true sentiment=↑ positive

Reversing AI drug discovery: Belgian biotech Sightera raises €3M to learn from ‘extreme’ patient biology first

Belgian biotech Sightera raised €3 million to reverse the typical AI drug discovery process by first analyzing extreme patient biology to identify novel drug targets. The company's approach aims to improve clinical success rates by grounding AI predictions in real human data.

read1 min views1 publishedJul 17, 2026

Most AI drug discovery companies start by selecting a target and designing a molecule, then seeking biological validation.…

source & further reading
techfundingnews.com — original article From 100 layoffs to €404M: How Lithuania’s Kilo rebuilt itself as a venture studio using AI Tyred bags £2.5M to build the AI platform that predicts your bike will break down before it actually does This Imperial College spinout using physics AI to run the world’s refineries just raised $20M from KBR and Databricks
── more in #artificial-intelligence 4 stories · sorted by recency
── more on @sightera 3 stories trending now
sponsored brought to you by zahid.host 4,200+ EU-deployed projects
reading about agents? ship yours in a single git push.

Run your AI side-project on zahid.host

EU-based hosting, git-push deploys, automatic HTTPS, no cold starts. Free tier with a custom domain — perfect for shipping the agent you just read about.

$git push zahid main
→ Live at https://your-agent.zahid.host ✓
Get free account → Pricing
from €0/mo · no card required
LIVE [news/reversing-ai-drug-di…] indexed:0 read:1min 2026-07-17 · —